ClinicalTrials.govpublic full text
Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
leukemia, refractory chronic lymphocytic leukemia, 06-138, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 979684
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.